Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4635 studies found for:    "Depressive Disorder" [DISEASE]
Show Display Options
RSS Create an RSS feed from your search for:
"Depressive Disorder" [DISEASE]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
Condition: Depressive Disorder
Intervention: Drug: Duloxetine Hydrochloride
2 Completed Major Depressive Disorder Study In Adults
Condition: Major Depressive Disorder
Intervention: Drug: paroxetine CR
3 Terminated Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: ABT-436;   Drug: Escitalopram;   Drug: Placebo
4 Completed Safety Study of F2695 SR in Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: F2695 SR
5 Completed
Has Results
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Vilazodone;   Drug: Placebo to citalopram;   Drug: Placebo to vilazodone;   Drug: Citalopram
6 Completed
Has Results
Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Dose-matched placebo;   Drug: Vilazodone
7 Completed Safety and Efficacy of Vilazodone in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Placebo;   Drug: Vilazodone
8 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
9 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
10 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
11 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release 10mg;   Drug: Desvenlafaxine Succinate Sustained-Release 50 mg;   Drug: placebo
12 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
13 Completed
Has Results
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine succinate sustained release 50 mg;   Drug: Desvenlafaxine succinate sustained release 25 mg;   Drug: Placebo
14 Completed Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: cariprazine;   Drug: placebo
15 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release (DVS SR);   Drug: placebo
16 Completed Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Device: transcranial direct current stimulation;   Drug: Sertraline;   Other: double placebo
17 Completed Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: DVS-233 SR
18 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: desvenlafaxine succinate sustained release;   Genetic: Genotyping
19 Completed Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Diluent / Insulin;   Drug: Insulin / Diluent
20 Completed A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: GSK561679;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.